Thursday, 8 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Tatva Chintan Pharma Chem Ltd

NSE: TATVA · BSE: 543321 · Chemicals & Petrochemicals · 28 announcements

Tatva Chintan Pharma Chem Ltd news stories on ALFA NewsRead the news →
Share price
₹1,991.20
Market cap
₹4,658 Cr
Revenue (annual)
₹505.9 Cr
Net profit (annual)
₹42.05 Cr
P/E (TTM)
90.7×Sector 36.8×
Promoter holding
72.02%+0.00% QoQ
FII holding
3.93%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

19:10 IST NSE
Annual General Meeting

Tatva Chintan Pharma Chem Annual General Meeting

The company held its 30th Annual General Meeting on September 25, 2026. Shareholders considered and approved items including financial statements and director re-appointments.

14:28 IST BSE
Annual General Meeting

Tatva Chintan Pharma Chem Annual General Meeting

Tatva Chintan Pharma Chem Limited has scheduled its 30th Annual General Meeting for September 25, 2026. Key agenda items include dividend declaration and director re-appointments.

14:26 IST NSE
Annual General Meeting

Tatva Chintan Pharma Chem Annual General Meeting

Tatva Chintan Pharma Chem Limited scheduled its 30th AGM for September 25, 2026. Key agenda items include dividend declaration and increasing borrowing limits to ₹1,000 Crore.

Value
₹1,000 Cr